Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takemasa Tsuji

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of the American Chemical Society|May 22, 2026
A Rapid Binder Discovery Workflow for Engineering Mini-Protein DegradersJingzhou Yang, Matthew J Styles, Kanokpol Aphicho, et al.
Blood|March 26, 2005
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genesTakemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, et al.
Plos One|August 8, 2014
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancerSayeema Daudi, Kevin H Eng, Paulette Mhawech-Fauceglia, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
WHSC1/NSD2 regulates immune infiltration in prostate cancerMuzamil Y Want, Takemasa Tsuji, Prashant K Singh, et al.
European Journal of Immunology|February 26, 2013
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenesMichiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, et al.
Journal for Immunotherapy of Cancer|August 30, 2023
BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer controlA J Robert McGray, Jessie L Chiello, Takemasa Tsuji, et al.
Research Square|October 27, 2023
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8<sup>+</sup> T CellsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
International Immunology|September 8, 2004
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiationAkihiko Hoshino, Takemasa Tsuji, Junko Matsuzaki, et al.
Frontiers in Immunology|May 24, 2021
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells <i>via</i> Aryl Hydrocarbon Receptor ActivationAdaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, et al.
Cell Reports|March 16, 2023
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantationHemn Mohammadpour, Takemasa Tsuji, Cameron R MacDonald, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|May 22, 2026
A Rapid Binder Discovery Workflow for Engineering Mini-Protein DegradersJingzhou Yang, Matthew J Styles, Kanokpol Aphicho, et al.
Blood|March 26, 2005
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genesTakemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, et al.
Plos One|August 8, 2014
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancerSayeema Daudi, Kevin H Eng, Paulette Mhawech-Fauceglia, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
WHSC1/NSD2 regulates immune infiltration in prostate cancerMuzamil Y Want, Takemasa Tsuji, Prashant K Singh, et al.
European Journal of Immunology|February 26, 2013
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenesMichiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, et al.
Journal for Immunotherapy of Cancer|August 30, 2023
BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer controlA J Robert McGray, Jessie L Chiello, Takemasa Tsuji, et al.
Research Square|October 27, 2023
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8<sup>+</sup> T CellsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
International Immunology|September 8, 2004
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiationAkihiko Hoshino, Takemasa Tsuji, Junko Matsuzaki, et al.
Frontiers in Immunology|May 24, 2021
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells <i>via</i> Aryl Hydrocarbon Receptor ActivationAdaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, et al.
Cell Reports|March 16, 2023
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantationHemn Mohammadpour, Takemasa Tsuji, Cameron R MacDonald, et al.
Pageof 6